Type | Public | |
Founded | 1996 | |
HQ | Dublin, IE | Map |
Website | theravance.com | |
Overall Culture | B- | More |
USD | |
---|---|
Revenue (FY, 2018) | 60.4m |
Revenue growth (FY, 2017 - FY, 2018), % | 292.4% |
Gross profit (FY, 2018) | 59.7m |
Gross profit margin (FY, 2018), % | 98.8% |
Net income (FY, 2018) | (215.5m) |
EBIT (FY, 2018) | (238.8m) |
Market capitalization (8-Jan-2021) | 1.1b |
Closing stock price (8-Jan-2021) | 17.7 |
Cash (31-Dec-2018) | 378.0m |
EV | 976.7m |
USD | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|
Cash | 344.7m | 89.0m | 378.0m |
Accounts Receivable | 646.0k | 2.3m | 620.0k |
Inventories | 12.2m | 16.8m | |
Current Assets | 528.5m | 378.7m | 532.8m |
USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|
Cash | 128.8m | 148.4m | 86.6m | 169.9m | 139.6m | 91.3m | 125.8m | 103.9m | 101.2m |
Accounts Receivable | 1.5m | 1.9m | 873.0k | 1.2m | 1.3m | 1.6m | 2.0m | 3.4m | 3.0m |
Inventories | 9.4m | 9.8m | 12.5m | 13.2m | 12.1m | 15.3m | 17.2m | 17.9m | 17.9m |
Current Assets | 238.8m | 303.1m | 274.0m | 421.5m | 384.9m | 367.1m | 446.8m | 386.7m | 332.6m |
USD | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|
Net Income | (190.7m) | (285.4m) | (215.5m) |
Depreciation and Amortization | 3.1m | 4.0m | 3.2m |
Inventories | (3.2m) | (7.3m) | (1.6m) |
Accounts Payable | (16.4m) | 3.8m | 3.6m |
USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (42.1m) | (89.4m) | (123.3m) | (65.3m) | (131.6m) | (198.5m) | (65.1m) | (105.9m) | (165.3m) |
Depreciation and Amortization | 699.0k | 1.2m | 1.9m | 1.1m | 2.1m | 3.0m | 900.0k | 1.7m | 2.3m |
Inventories | 134.0k | 157.0k | (1.8m) | 140.0k | (497.0k) | (3.0m) | (371.0k) | (351.0k) | (552.0k) |
Accounts Payable | (9.4m) | (10.8m) | (12.8m) | 2.0m | 4.8m | 3.5m | (449.0k) | (2.3m) | (1.7m) |
USD | Q1, 2016 |
---|---|
Financial Leverage | 1.2 x |
Company Name | Date | Deal Size |
---|---|---|
Theravance Biopharma Antibiotics IP | ||
Theravance Biopharma Ireland Limited | ||
Theravance Biopharma R&D | ||
Theravance Biopharma R&D IP | ||
Theravance Biopharma UK Limited | ||
Theravance Biopharma US | ||
Triple Royalty Sub LLC |
Theravance Biopharma revenue breakdown by geographic segment: 18.4% from Europe, 81.6% from US and 0.0% from Other
B-
75/100
A
80/100
D
54/100
When was Theravance Biopharma founded?
Theravance Biopharma was founded in 1996.
Who are Theravance Biopharma key executives?
Theravance Biopharma's key executives are Rick Winningham, Gary Barrera and Eran Broshy.
How many employees does Theravance Biopharma have?
Theravance Biopharma has 363 employees.
What is Theravance Biopharma revenue?
Latest Theravance Biopharma annual revenue is $60.4 m.
What is Theravance Biopharma revenue per employee?
Latest Theravance Biopharma revenue per employee is $166.3 k.
Who are Theravance Biopharma competitors?
Competitors of Theravance Biopharma include Acceleron Pharma, Inflazome and Prothena.
Where is Theravance Biopharma headquarters?
Theravance Biopharma headquarters is located at Connaught House, 1 Burlington Rd, Dublin.
Where are Theravance Biopharma offices?
Theravance Biopharma has offices in Dublin and San Francisco.
How many offices does Theravance Biopharma have?
Theravance Biopharma has 2 offices.
Receive alerts for 300+ data fields across thousands of companies